FMR LLC 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 12:03 pm Sale |
2024-02-09 | 13G | Karuna Therapeutics, Inc. KRTX |
FMR LLC | 858,944 2.276% |
-2,007,050 (-70.03%) |
Filing |
| 2024-01-10 08:53 am Sale |
2024-01-09 | 13G | Karuna Therapeutics, Inc. KRTX |
FMR LLC | 2,865,994 7.596% |
-2,286,995 (-44.38%) |
Filing |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Karuna Therapeutics, Inc. KRTX |
FMR LLC | 5,152,989 14.995% |
578,883 (+12.66%) |
Filing |
| 2022-02-09 09:22 am Sale |
2022-02-08 | 13G | Karuna Therapeutics, Inc. KRTX |
FMR LLC | 4,574,106 15.440% |
-90,000 (-1.93%) |
Filing |
| 2021-02-08 10:25 am Purchase |
2021-02-05 | 13G | Karuna Therapeutics, Inc. KRTX |
FMR LLC | 4,664,106 17.399% |
762,193 (+19.53%) |
Filing |